218 related articles for article (PubMed ID: 12486659)
1. Inhaled nitric oxide for perioperative management of an adult patient with atrial septal defect and severe pulmonary hypertension.
Kim JH; Ham BM; Kim YL; Ahn H; Noh CI
J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):746-8. PubMed ID: 12486659
[No Abstract] [Full Text] [Related]
2. [The usefulness of inhaled nitric oxide in the treatment of pulmonary hypertension in the postoperative period of cardiac surgery in infancy].
de Lucas García N; López-Herce Cid J; Alcaraz Romero A; Carrillo Alvarez A; Seriñá Ramírez C
An Esp Pediatr; 1996 Apr; 44(4):373-6. PubMed ID: 8796940
[No Abstract] [Full Text] [Related]
3. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of pulmonary hypertension after ventricular septal defect closure and perioperative response to nitric oxide.
Luciani GB; Pessotto R; Mazzucco A
Int J Cardiol; 1998 Jan; 63(1):85-7. PubMed ID: 9482150
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
[TBL] [Abstract][Full Text] [Related]
6. Repair of ventricular septal defect in a child with severe pulmonary hypertension--response to inhaled nitric oxide.
Cregg N; Casey W
Paediatr Anaesth; 1997; 7(3):255-8. PubMed ID: 9189975
[TBL] [Abstract][Full Text] [Related]
7. The use of nitrogen and nitric oxide to control pulmonary blood flow in the Norwood operation.
Maegawa Y; Mizobe T; Yamagishi M; Shime N; Tanaka Y
J Cardiothorac Vasc Anesth; 2002 Apr; 16(2):264-6. PubMed ID: 11957186
[No Abstract] [Full Text] [Related]
8. [Atrial septal defect and severe pulmonary hypertension in an adult who needed nitric oxide inhalation after repair].
Imanaka K; Kotsuka Y; Takamoto S; Furuse A; Inoue K; Shirai T
Kyobu Geka; 1998 Mar; 51(5):403-5. PubMed ID: 9594501
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension.
Tissières P; Nicod L; Barazzone-Argiroffo C; Rimensberger PC; Beghetti M
Ann Thorac Surg; 2004 Sep; 78(3):e48-50. PubMed ID: 15337084
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
15. Pro: Inhaled nitric oxide should be used routinely in patients undergoing lung transplantation.
Lang JD; Lell W
J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):785-9. PubMed ID: 11748534
[No Abstract] [Full Text] [Related]
16. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.
Atz AM; Adatia I; Jonas RA; Wessel DL
Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419
[TBL] [Abstract][Full Text] [Related]
17. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
Ricksten S
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
[TBL] [Abstract][Full Text] [Related]
18. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
[No Abstract] [Full Text] [Related]
19. [Management of pulmonary circulation: mechanism of action of vasoactive substances].
Yokochi A; Maruyama J; Maruyama K
Masui; 1997 Nov; 46 Suppl():S36-41. PubMed ID: 9508582
[No Abstract] [Full Text] [Related]
20. Con: Inhaled nitric oxide should not be used routinely in patients undergoing lung transplantation.
McQuitty CK
J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):790-2. PubMed ID: 11748535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
